These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
540 related articles for article (PubMed ID: 15898123)
21. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease. Oztas MO; Onder M; Gurer MA; Bukan N; Sancak B Clin Exp Dermatol; 2005 Jan; 30(1):61-3. PubMed ID: 15663506 [TBL] [Abstract][Full Text] [Related]
22. Serum leptin levels in patients with ocular and nonocular Behçet's disease. Yalçindağ FN; Kisa U; Batioğlu F; Yalçindağ A; Ozdemir O; Cağlayan O Mediators Inflamm; 2007; 2007():31986. PubMed ID: 17641728 [TBL] [Abstract][Full Text] [Related]
23. Circulated activated platelets and increased platelet reactivity in patients with Behçet's disease. Akar S; Ozcan MA; Ateş H; Gürler O; Alacacioglu I; Ozsan GH; Akkoç N; Ozkan S; Demirkan F; Onen F Clin Appl Thromb Hemost; 2006 Oct; 12(4):451-7. PubMed ID: 17000890 [TBL] [Abstract][Full Text] [Related]
24. Serum mannose-binding lectin levels are decreased in behcet's disease and associated with disease severity. Inanc N; Mumcu G; Birtas E; Elbir Y; Yavuz S; Ergun T; Fresko I; Direskeneli H J Rheumatol; 2005 Feb; 32(2):287-91. PubMed ID: 15693089 [TBL] [Abstract][Full Text] [Related]
25. Serum interleukin-8 as a serologic marker of activity in Behçet's disease. Gür-Toy G; Lenk N; Yalcin B; Aksaray S; Alli N Int J Dermatol; 2005 Aug; 44(8):657-60. PubMed ID: 16101867 [TBL] [Abstract][Full Text] [Related]
26. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation? Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555 [TBL] [Abstract][Full Text] [Related]
27. Androgen receptor levels in the sebaceous glands of papulopustular lesions from patients with Behçet's disease and acne vulgaris: a controlled study. Durusoy C; Alpsoy E; Elpek O; Karpuzoglu G Adv Clin Path; 2002 Apr; 6(2):87-93. PubMed ID: 19753730 [TBL] [Abstract][Full Text] [Related]
28. Classifying patients with Behçet's disease for disease severity, using a discriminating analysis method. Polat M; Vahaboglu G; Onde U; Eksioglu M Clin Exp Dermatol; 2009 Mar; 34(2):151-5. PubMed ID: 19187295 [TBL] [Abstract][Full Text] [Related]
29. Study of the correlation of serum selenium level with Behcet's disease. Esalatmanesh K; Jamshidi A; Shahram F; Davatchi F; Masoud SA; Soleimani Z; Salesi M; Ghaffarpasand I Int J Rheum Dis; 2011 Oct; 14(4):375-8. PubMed ID: 22004235 [TBL] [Abstract][Full Text] [Related]
30. Reduced erythrocyte deformability in active and untreated Behçet's disease patients. Tatlican S; Duran FS; Eren C; Eskioglu F; Dikmenoglu N; Oktay B; Durmazlar SP; Canpolat F Int J Dermatol; 2010 Feb; 49(2):167-71. PubMed ID: 20465640 [TBL] [Abstract][Full Text] [Related]
31. Surgical treatment of Budd-Chiari syndrome induced by Behcet's disease. Kuniyoshi Y; Koja K; Miyagi K; Uezu T; Yamashiro S; Arakaki K; Mabuni K; Senaha S Ann Thorac Cardiovasc Surg; 2002 Dec; 8(6):374-80. PubMed ID: 12517299 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of leptin level and Ob gene polymorphism in patients with Behcet's disease. Okudan N; Acar H; Gökbel H; Mevlitoğlu I; Sari F Arch Dermatol Res; 2006 Aug; 298(3):127-30. PubMed ID: 16786343 [TBL] [Abstract][Full Text] [Related]
34. Bronchial hyperreactivity and immunoglobulin E in Behçet's disease. Kalpaklioğlu AF; Gürbüz L; Gürler A; Demirel YS Allergol Immunopathol (Madr); 1997; 25(4):182-8. PubMed ID: 9269508 [TBL] [Abstract][Full Text] [Related]
35. Fas (CD95) and bcl-2 expression in active skin lesions of Behçet's disease. Bariş YS; Yildiz L; Sentürk N; Kandemir B J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):569-72. PubMed ID: 16164710 [TBL] [Abstract][Full Text] [Related]
36. Behçet's disease and hearing loss. AK E; Harputluoglu U; Oghan F; Baykal B Auris Nasus Larynx; 2004 Mar; 31(1):29-33. PubMed ID: 15041051 [TBL] [Abstract][Full Text] [Related]
37. Von Willebrand factor antigen levels in Behçet disease. Beyan E; Sadikoğlu B; Ertuğrul E; Beyan C Am J Hematol; 2005 May; 79(1):70-2. PubMed ID: 15849757 [TBL] [Abstract][Full Text] [Related]
38. MALDI-TOF/TOF-MS reveals elevated serum haptoglobin and amyloid A in Behcet's disease. Mao L; Dong H; Yang P; Zhou H; Huang X; Lin X; Kijlstra A J Proteome Res; 2008 Oct; 7(10):4500-7. PubMed ID: 18754684 [TBL] [Abstract][Full Text] [Related]
39. Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease? Keskin D; Keskin G; Inal A; Ozışık L Acta Clin Belg; 2014 Aug; 69(4):246-50. PubMed ID: 25012748 [TBL] [Abstract][Full Text] [Related]
40. A comparison between the effects of low (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal cortex functions with Behçet's disease. Colak R; Ozkan Y; Cengiz SU; Saral Y; Kandi BC; Halifeoglu I J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):721-5. PubMed ID: 16836503 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]